Teenage Girl Walks Again After Finally Getting Diagnosed With Complement C1q Deficiency and Bone Marrow Transplant
source: pixabay.com

Teenage Girl Walks Again After Finally Getting Diagnosed With Complement C1q Deficiency and Bone Marrow Transplant

  A young girl in Mauritius, an island in the Indian Ocean, has recently been given a second chance at a normal life after receiving a rare disease diagnosis and…

Continue Reading Teenage Girl Walks Again After Finally Getting Diagnosed With Complement C1q Deficiency and Bone Marrow Transplant
Man With Urea Cycle Disorder is the First Person in Canada to be Treated With Intravenous Gene Therapy
NeuPaddy / Pixabay

Man With Urea Cycle Disorder is the First Person in Canada to be Treated With Intravenous Gene Therapy

According to a story from ctvnews.ca, a recent treatment with gene therapy appears to have changed the life of thirty year old Josh McQuillin, who has a urea cycle disorder,…

Continue Reading Man With Urea Cycle Disorder is the First Person in Canada to be Treated With Intravenous Gene Therapy
Study Indicates Safety of New Potential Treatment for Swallowing Dysfunction in Kennedy Disease
source: pixabay.com

Study Indicates Safety of New Potential Treatment for Swallowing Dysfunction in Kennedy Disease

Kennedy disease or, Spinal and Bulbar Muscular Atrophy (SBMA) is a form of Spinal Muscular Atrophy (SMA). SBMA causes muscle weakness throughout the limbs which results in impaired mobility (typical…

Continue Reading Study Indicates Safety of New Potential Treatment for Swallowing Dysfunction in Kennedy Disease

New Biosimilar Product to Humira Could Be Cheaper and Just as Effective for Ankylosing Spondylitis Patients

The most common treatment for autoimmune conditions such as ankylosing spondylitis, plaque psoriasis, Crohn's disease, juvenile idiopathic arthritis, and rheumatoid arthritis is currently a drug called Humira, created by AbbVie.…

Continue Reading New Biosimilar Product to Humira Could Be Cheaper and Just as Effective for Ankylosing Spondylitis Patients

How Changing to Outcome-Based Reimbursement Models is Better for Rare Disease Patients

Shifting Contracts Over the years the United States healthcare system has shifted more toward reimbursement models that are outcome-based instead of service-based. In essence, this means that instead of paying…

Continue Reading How Changing to Outcome-Based Reimbursement Models is Better for Rare Disease Patients

Preliminary Data from Phase 1 Trial for Multiple Myeloma Indicates Complete Response in a Patient

Phase 1 Trial A Phase 1 trial by Gamida Cell is examining a new potential treatment option for patients with multiple myeloma and relapsed/refractory non-Hodgkin's lymphoma who have not responded…

Continue Reading Preliminary Data from Phase 1 Trial for Multiple Myeloma Indicates Complete Response in a Patient
Bioscience Companies in Ohio Take Aim at Rare Diseases
source: pixabay.com

Bioscience Companies in Ohio Take Aim at Rare Diseases

According to a story from BioPortfolio, Rare Disease Day, which took place on February 28th, 2019, serves as a time of reflection on the progress that has been made in…

Continue Reading Bioscience Companies in Ohio Take Aim at Rare Diseases
Experimental Treatment Could be Potential Breakthrough for Generalized Pustular Psoriasis
jarmoluk / Pixabay

Experimental Treatment Could be Potential Breakthrough for Generalized Pustular Psoriasis

According to a story from dubainewstoday.blogspot.com, the data from a Phase I clinical trial suggests that an experimental drug candidate from the pharmaceutical company Boehringer Ingelheim could substantially improve the…

Continue Reading Experimental Treatment Could be Potential Breakthrough for Generalized Pustular Psoriasis

Study Investigates the Most Predictive Indicators of Bronchopulmonary Dysplasia

What is Bronchopulmonary Dysplasia? Bronchopulmonary Dysplasia (BPD) is a diagnosis most commonly given to premature newborns. In children, BPD is also the most common cause of Pulmonary Hypertension (PH). Premature babies often develop…

Continue Reading Study Investigates the Most Predictive Indicators of Bronchopulmonary Dysplasia

First Potential Gene Therapy for Tay-Sachs Disease Produces Positive Results at Three Month Mark

Tay-Sachs disease is a rare, genetic and sadly fatal condition. It's a neurodegenerative disorder caused by an impaired production of the β-Hexosaminidase A enzyme (HEXA). Symptoms of this condition include listlessness, diminishing…

Continue Reading First Potential Gene Therapy for Tay-Sachs Disease Produces Positive Results at Three Month Mark

FDA Regulations and the Critical Differences Between Medical Device Trials and Pharmaceutical Trials

Medical devices include ECG electrodes, bandages, cardiac pacemakers, thermometers, and hemodialysis machines. A comparison of clinical trials shows that medical device trials are somewhat similar to pharmaceutical trials that evaluate drugs,…

Continue Reading FDA Regulations and the Critical Differences Between Medical Device Trials and Pharmaceutical Trials